Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T20:36:17.956Z.
Calculation as of: 2026-10-06T20:36:17.956Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6caa0376099c5ebdf209f9b018955c4d65987c3db8176dc1b5ff0a1c5aca19bf
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Bright Minds Biosciences Inc.
Market Cap
$472.23M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$469.12M
EV/EBIT Ratio
N/A
TTM Avg
197.32x
3Y Avg
197.32x
5Y Avg
197.32x
Market Cap
$475.91M
EV/EBIT Ratio
N/A
TTM Avg
5.92x
3Y Avg
17.76x
5Y Avg
17.76x
Market Cap
$483.54M
EV/EBIT Ratio
14.85x
TTM Avg
10.51x
3Y Avg
8.16x
5Y Avg
8.11x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $472.23M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $471.65M | N/A | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $471.57M | N/A | N/A | N/A | N/A |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | N/A | 197.32x | 197.32x | 197.32x |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | N/A | 5.92x | 17.76x | 17.76x |
| Kamada Ltd. (KMDA)vs › | $467.90M | 16.18x | 15.53x | 17.24x | 21.68x |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | N/A | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 14.85x | 10.51x | 8.16x | 8.11x |
| Evolus, Inc. (EOLS)vs › | $486.01M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $452.54M | 36.59x | 22.84x | 18.67x | 19.86x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
